EGF anticorps
Aperçu rapide pour EGF anticorps (ABIN329284)
Antigène
Voir toutes EGF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Recognizes human Pro-EGF.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
NS0-derived, recombinant human Pro-EGF.
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA (0.5 - 1 μg/mL), WB (0.1 - 0.2 μg/mL)
Usage: Suitable for use in Direct ELISA and Western Blot. Direct ELISA: 0.5-1 μg/mL detection limit for rhPro-EGF ~0.2 ng/well. Western Blot: 0.1-0.2 μg/mL detection limit for rhPro-EGF ~10 ng/lane under non-reducing and reducing conditions. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute, 200 μL 40-50 % glycerol, PBS.
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder from PBS, 5 % trehalose. Reconstitute, 200 μL40-50 % glycerol, PBS.
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Autre désignation
- EGF
-
Sujet
-
Name/Gene ID: EGF
Synonyms: EGF, Beta-urogastrone, HOMG4, URG, Epidermal growth factor, Pro-epidermal growth factor -
ID gène
- 1950
-
UniProt
- P01133
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Antigène
-